ArticleBlood advances2020

The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells.

Kamira Maharaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.